4.7 Article

Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 225, 期 2, 页码 287-294

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiab338

关键词

HIV infection; antiretroviral therapy; aging; epigenetic age acceleration

资金

  1. Instituto de Salud Carlos III-European Regional Development Fund [PI18/00569]
  2. Instituto de Salud Carlos III-Fondo Social Europeo [FI17/00194, CM17/0064, CM19/00059]
  3. Consejeria de Ciencia, Universidades e Innovacion, Comunidad de Madrid-Fondo Social Europeo [PEJ2019-TL/BMD-12514]

向作者/读者索取更多资源

The study found that epigenetic aging did not continue to accelerate in long-term aviremic HIV-infected adults after 4 years of successful ART. Changes in EAA measures were independent of CD4 cell counts, ART regimen, or other HIV-related factors. Some participants experienced serious clinical events during the study, with a trend towards higher levels of EAA measures at baseline being associated with these events after adjusting for confounders.
Background. Human immunodeficiency virus (HIV) infection induces epigenetic age acceleration (EAA), but it remains unclear whether epigenetic aging continues to accelerate during successful antiretroviral therapy (ART) and prolonged virological suppression. Methods. We longitudinally analyzed 63 long-term aviremic HIV-infected adults. Using blood DNA methylation patterns, we calculated EAA measures based on 3 epigenetic clocks (Horvath's clock, PhenoAge, and GrimAge). We recorded the emergence of serious AIDS-related and non-AIDS-related events throughout the study to assess its association with EAA. Results. All participants were on stable ART and were virologically suppressed. After 4 years of follow-up, PhenoAge-EAA and GrimAge-EAA showed no differences, whereas Horvath-EAA slightly decreased (median difference, -0.53 years; P = .015). Longitudinal changes in EAA measures were independent of changes in CD4 cell counts, the ART regimen, or other HIV-related factors. Nineteen percent of participants experienced a serious clinical event during the study. Horvath-EAA was significantly higher at baseline in participants with clinical events (P = .027). After adjusting for confounders, we found a trend toward an association of higher levels of all EAA measures at baseline with serious clinical events. Conclusions. Epigenetic aging did not accelerate in long-term aviremic HIV-infected adults after 4 years of successful ART. EAA measures deserve further study as potential tools for predicting clinical events.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据